{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:33:52Z","timestamp":1747172032735,"version":"3.40.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.urology.2013.11.030","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T01:21:21Z","timestamp":1393377681000},"page":"675.e7-675.e11","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Chronic Treatment With Cilostazol, a Phosphodiesterase 3 Inhibitor, on Female Rat Bladder in a Partial Bladder Outlet Obstruction Model"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9941-3758","authenticated-orcid":false,"given":"Seiji","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiro","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2013.11.030_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1442-2042.2011.02903.x","article-title":"Causative significance of bladder blood flow in lower urinary tract symptoms","volume":"19","author":"Matsumoto","year":"2012","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2013.11.030_bib2","first-page":"1626","article-title":"Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit","volume":"161","author":"Azadzoi","year":"1999","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2013.11.030_bib3","first-page":"1349","article-title":"Correlation between the structure and function of the rabbit urinary bladder following partial outlet obstruction","volume":"163","author":"Gosling","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2013.11.030_bib4","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/nau.20843","article-title":"The effects of chronic hyperlipidemia on bladder function in myocardial infarction-prone Watanabe heritable hyperlipidemic (WHHLMI) rabbits","volume":"29","author":"Yoshida","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2013.11.030_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/nau.21073","article-title":"The effect of atherosclerosis-induced chronic bladder ischemia on bladder function in the rat","volume":"31","author":"Nomiya","year":"2012","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2013.11.030_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.urology.2009.05.045","article-title":"Effects of tamsulosin on bladder blood flow and bladder function in rats with bladder outlet obstruction","volume":"75","author":"Okutsu","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urology.2013.11.030_bib7","first-page":"2470","article-title":"Effect of tamsulosin on bladder blood flow and bladder function in a rat model of bladder over distention\/emptying induced bladder overactivity","volume":"186","author":"Okutsu","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2013.11.030_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1464-410X.2007.07339.x","article-title":"alpha-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms","volume":"101","author":"Pinggera","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2013.11.030_bib9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1464-410X.2008.08185.x","article-title":"Effects of chronic treatment with vardenafil, a phosphodiesterase 5 inhibitor, on female rat bladder in a partial bladder outlet obstruction model","volume":"103","author":"Matsumoto","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2013.11.030_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11255-009-9564-7","article-title":"Chronic treatment with a PDE5 inhibitor increases contractile force of normal bladder in rats","volume":"42","author":"Matsumoto","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2013.11.030_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/nau.20999","article-title":"Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action","volume":"30","author":"Andersson","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2013.11.030_bib12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.eururo.2011.08.005","article-title":"Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial","volume":"60","author":"Porst","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2013.11.030_bib13","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.eururo.2012.02.033","article-title":"A\u00a0systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with \u03b1-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"61","author":"Gacci","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2013.11.030_bib14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/01.shk.0000228800.56223.db","article-title":"Comparison of the protective effects of type III phosphodiesterase (PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in mice","volume":"26","author":"Iba","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.urology.2013.11.030_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00005344-200210000-00011","article-title":"New mechanism of action for cilostazol: interplay between adenosine and cilostazol in inhibiting platelet activation","volume":"40","author":"Sun","year":"2002","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.urology.2013.11.030_bib16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1440-1681.2011.05550.x","article-title":"Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels","volume":"38","author":"Bai","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.urology.2013.11.030_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/153857440503900104","article-title":"Inferior canine hind limb ischemia and reperfusion impairs femoral artery endothelium-dependent wall relaxation","volume":"39","author":"Joviliano","year":"2005","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.urology.2013.11.030_bib18","first-page":"1124","article-title":"The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man","volume":"35","author":"Akiyama","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.urology.2013.11.030_bib19","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1161\/STROKEAHA.110.609834","article-title":"Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats","volume":"42","author":"Oyama","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.urology.2013.11.030_bib20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1213\/ANE.0b013e3181cb5cdd","article-title":"The effects of the phosphodiesterase inhibitor olprinone on global cerebral ischemia","volume":"110","author":"Okayama","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.urology.2013.11.030_bib21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3109\/00498254.2011.590242","article-title":"Sex differences in pharmacokinetics of cilostazol in rats","volume":"41","author":"Kamada","year":"2011","journal-title":"Xenobiotica"},{"issue":"Suppl 2","key":"10.1016\/j.urology.2013.11.030_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1464-410X.2006.06102.x","article-title":"Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology","volume":"97","author":"McVary","year":"2006","journal-title":"BJU Int"},{"issue":"Suppl 2","key":"10.1016\/j.urology.2013.11.030_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1464-410X.2006.06104.x","article-title":"Impact of medical treatments for benign prostatic hyperplasia on sexual function","volume":"97","author":"Giuliano","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2013.11.030_bib24","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2125.2011.04034.x","article-title":"Anti-platelet therapy: phosphodiesterase inhibitors","volume":"72","author":"Gresele","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.urology.2013.11.030_bib25","first-page":"43A","article-title":"Relaxation of bladder strips by inhibition of cyclic nucleotide phosphodiesterase type 4 (PDE4)","volume":"173","author":"Snyder","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2013.11.030_bib26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1464-410X.2006.06643.x","article-title":"Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor","volume":"99","author":"Nishiguchi","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2013.11.030_bib27","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/nau.20485","article-title":"Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS","volume":"26","author":"Andersson","year":"2007","journal-title":"Neurourol Urodyn"},{"first-page":"832","year":"1996","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","key":"10.1016\/j.urology.2013.11.030_bib28"},{"key":"10.1016\/j.urology.2013.11.030_bib29","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0090-4295(01)01291-2","article-title":"Aspirin treatment improves bladder function after outlet obstruction in rabbits","volume":"58","author":"Schr\u00f6der","year":"2001","journal-title":"Urology"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429513015185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429513015185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T06:24:11Z","timestamp":1538807051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429513015185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0090429513015185"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2013.11.030","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}